Sojo-Vega L, Recasens M, Martínez J, Aguilera A, Ayala M, Admetlla N, Pellicer P, Blay C, Fabregat B, Esteve-Serra M, Riera L, Barahona R, Xifra G, Esteve E, Biarnés J, Pérez D, Gifre G, Mauri S, Costa E, Wos M, Buxó M, Fernández-Balsells M
Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes.
Sojo L, Santos-González E, Riera L, Aguilera A, Barahona R, Pellicer P, Buxó M, Mayneris-Perxachs J, Fernandez-Balsells M, Fernández-Real JM
Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes
Enchev-Hristov E, Esteve-Serra M, Reyes-Céspedes LM, Barahona-San Millán R, Recasens-Sala M, Sojo-Vega L, Costa-Lima E, Fernández-Real JM, Ricart-Engel W, Fernández-Balsells M
Assessing the quality of the evidence underlying recommendations in type 2 diabetes' commonly used clinical practice guidelines